Multiple sclerosis and Cirrhosis alcoholic

Summary:

Cirrhosis alcoholic is found among people with Multiple sclerosis, especially for people who are male, 50-59 old.

The study analyzes which people have Cirrhosis alcoholic with Multiple sclerosis. It is created by eHealthMe based on reports of 14 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 14, 2022

14 people who have Multiple Sclerosis and Cirrhosis Alcoholic are studied.


What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,989 drugs and 1,266 conditions by eHealthMe.

What is Cirrhosis alcoholic?

Cirrhosis alcoholic (chronic disease of the liver marked by degeneration of cells, inflammation, and fibrous thickening of tissue caused by alcoholism) is found to be associated with 363 drugs and 162 conditions by eHealthMe.

Number of Cirrhosis alcoholic in Multiple sclerosis reports submitted per year:

Would you have Cirrhosis alcoholic when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experienced Cirrhosis Alcoholic *:

  • female: 42.86 %
  • male: 57.14 %

Age of people who have Multiple Sclerosis and experienced Cirrhosis Alcoholic *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 87.5 %
  • 60+: 12.5 %

Common co-existing conditions for these people *:

  1. Neuropathy Peripheral (surface nerve damage): 1 person, 7.14%
  2. Gastritis (inflammation of stomach): 1 person, 7.14%

Common drugs taken by these people *:

  1. Avonex: 7 people, 50.00%
  2. Tecfidera: 5 people, 35.71%
  3. Vitamin D: 3 people, 21.43%
  4. Ampyra: 3 people, 21.43%
  5. Vitamin B1: 2 people, 14.29%
  6. Tysabri: 2 people, 14.29%
  7. Tramadol: 2 people, 14.29%
  8. Lioresal: 2 people, 14.29%
  9. Spiriva: 2 people, 14.29%
  10. Ranitidine: 2 people, 14.29%

Common symptoms for these people *:

  1. Urinary Tract Infection: 6 people, 42.86%
  2. Weakness: 4 people, 28.57%
  3. Ascites (accumulation of fluid in the abdominal cavity): 4 people, 28.57%
  4. Memory Loss: 4 people, 28.57%
  5. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 3 people, 21.43%
  6. Diarrhea: 3 people, 21.43%
  7. Depression: 3 people, 21.43%
  8. Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 3 people, 21.43%
  9. Blindness Transient (sudden loss of vision): 3 people, 21.43%
  10. Pneumonia: 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Cirrhosis alcoholic?

Check whether Cirrhosis alcoholic is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Cirrhosis alcoholic:

All the drugs that are associated with Cirrhosis alcoholic:

All the conditions that are associated with Cirrhosis alcoholic:

How the study uses the data?

The study is based on Cirrhosis alcoholic and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: